Eduardo de Marchena, M.D., Receives AHA Cor Vitae Award

MIAMI--(Business Wire)--
Eduardo de Marchena, M.D., cofounder of Miami Cardiovascular
InnovationsCorporation and professor of medicine and surgery and associate dean
for international medicine at the University of Miami Miller School of Medicine,
was presented with the American Heart Association`s Cor Vitae award at the
American Heart Association`s 41st annual Miami-Dade Heart Ball on Saturday, May
30, 2009.

The Cor Vitae award is given to physicians whose focus is in cardiovascular
medicine or stroke and who demonstrate outstanding commitment and a proven track
record in the Dade County, Florida region. Upon receiving the award, Dr. de
Marchena said it was "humbling and a great honor to be recognized by the
American Heart Association and to be nominated by such excellent cardiologists,
cardiac surgeons and neurologists."

Together with Frank Avellanet, President and CEO, Dr. de Marchena founded Miami
Cardiovascular Innovations Corporation in March of 2006. Dr. de Marchena is an
internationally renowned cardiologist who has spearheaded multiple programs in
heart transplantation, interventional cardiology and founded the Atherosclerosis
Prevention and Treatment Center in addition to leading the International
Medicine Institute at the University of Miami Miller School of Medicine. With
more than 25 years of clinical experience, Dr. de Marchena is now spearheading
cardiovascular treatments overseas.

He is an internationally renowned expert in interventional cardiology, coronary
artery disease and congestive heart failure, with studies in more than 200
publications including The New England Journal of Medicine, Circulation and the
Journal of the American College of Cardiology. In addition to all his full-time
academic and medical duties, Dr. de Marchena provides clinical guidance to Miami
Cardiovascular Innovation`s product researchers and engineers.

William O`Neill, M.D., executive dean for clinical affairs at the Miller School
presented Dr. de Marchena with the Cor Vitae Award and described him a "leader
in every facet of cardiology, from research, to education, and treating
patients. Dr. de Marchena is a physician and scientist who continues to set the
bar for all of us working to conquer heart disease."

For more information, please visit the University of Miami Miller School of
Medicine`s International Medicine Institute by clicking here.

Miami Cardiovascular Innovations is a privately-held emerging company
headquartered in Miami, Florida and engaged in the development of cardiovascular
technologies, for more information on the company, please visit
www.miacardio.com.

Miami Cardiovascular Innovations Corporation
Frank Avellanet, President and CEO, 305-243-4840

Copyright Business Wire 2009